The Center for Drug Evaluation and Research (CDER) is engaged in numerous activities to protect and promote public health during the COVID-19 pandemic.
Please visit the webpages for contact information and to learn more about each area of activity.
CDER’s Work to Protect Public Health
Actions towards achieving critical goals during the COVID-19 Public Health Emergency
Coronavirus Treatment Acceleration Program (CTAP)
CTAP will use every available method to move new treatments to patients as quickly as possible, balancing patient needs for medicine while supporting trials to gather evidence and weighing the risks and benefits
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
For Updates on Twitter follow
Your source for the latest drug information.
Know the moment it happens.